Evaluation of transduction efficiency in macrophage colony-stimulating factor differentiated human macrophages using HIV-1 based lentiviral vectors
© Leyva et al; licensee BioMed Central Ltd. 2011
Received: 28 September 2010
Accepted: 31 January 2011
Published: 31 January 2011
Monocyte-derived macrophages contribute to atherosclerotic plaque formation. Therefore, manipulating macrophage function could have significant therapeutic value. The objective of this study was to determine transduction efficiency of two HIV-based lentiviral vector configurations as delivery systems for the transduction of primary human blood monocyte-derived macrophages.
Human blood monocytes were transduced using two VSV-G pseudotyped HIV-1 based lentiviral vectors containing EGFP expression driven by either native HIV-LTR (VRX494) or EF1α promoters (VRX1090). Lentiviral vectors were added to cultured macrophages at different times and multiplicities of infection (MOI). Transduction efficiency was assessed using fluorescence microscopy and flow cytometry. Macrophages transduced between 2 and 120 hours after culturing showed the highest transduction efficiency at 2-hours transduction time. Subsequently, cells were transduced 2 hours after culturing at various vector concentrations (MOIs of 5, 10, 25 and 50) to determine the amount of lentiviral vector particles required to maximally transduce human monocyte-derived macrophages. On day 7, all transduced cultures showed EGFP-positive cells by microscopy. Flow cytometric analysis showed with all MOIs a peak shift corresponding to the presence of EGFP-positive cells. For VRX494, transduction efficiency was maximal at an MOI of 25 to 50 and ranged between 58 and 67%. For VRX1090, transduction efficiency was maximal at an MOI of 10 and ranged between 80 and 90%. Thus, transductions performed with VRX1090 showed a higher number of EGFP-positive cells than VRX494.
This report shows that VSV-G pseudotyped HIV-based lentiviral vectors can efficiently transduce human blood monocyte-derived macrophages early during differentiation using low particle numbers that do not interfere with differentiation of monocytes into macrophages.
Coronary artery disease is the leading cause of death in the United States and other Western societies . Coronary artery disease develops as a consequence of lipid deposition and foam cell formation in the arterial wall leading to the development of atherosclerotic plaques . Atherosclerosis is considered an inflammatory disease in which the major cell types implicated are macrophages, smooth muscle cells, and T lymphocytes . Macrophages are present in virtually every atherosclerotic plaque and have an important role in foam cell and atherosclerotic plaque formation through the uptake and accumulation of cholesterol .
Circulating blood monocytes differentiate into macrophages. Monocytes can migrate through the blood vessel wall into surrounding tissue, where they differentiate into macrophages and accumulate in pathological tissue sites in the body. Macrophages produce proinflammatory and proangiogenic mediators, and function as host cells for pathogens. Due to these functions, macrophages can contribute to the initiation and progression of a wide variety of diseases. Therefore, directly manipulating these hematopoietic cell subsets could have significant therapeutic value .
Human blood monocyte differentiation into macrophages can be induced in vitro using three different methods: culture in 1) human serum (HS), 2) fetal bovine serum (FBS) with granulocyte-macrophage colony-stimulating factor (GM-CSF) or 3) FBS with macrophage colony-stimulating factor (M-CSF). In our experience, macrophages differentiated with HS or GM-CSF with FBS show similar phenotype and morphology (i.e., round cells resembling fried eggs) [6, 7]. However, the M-CSF differentiated monocyte-derived macrophage has a different phenotype characterized by an elongated shaped macrophage with numerous vacuoles corresponding to macropinosomes, and constitutive uptake of low-density lipoprotein (LDL) [8, 9].
Gene transfer methods have been attempted to manipulate gene expression in macrophages. Non-viral methods such as calcium phosphate precipitation, electroporation, and liposomal or polyethylenimine transfection are less time-consuming and allow use of a larger number of constructs per experiment than viral methods. However non-viral gene transfer methods are inefficient at transfecting macrophages . Viral systems generally give higher gene transfer efficiency and longer expression time than non-viral systems, but only allow the transfer of small sizes (less than 8 kb) of foreign DNA . Viral methods using adenoviruses have reported high transduction efficiency, but their lack of integration into the host cell genome makes the expression of any transferred gene transient [11–14]. Retroviruses (except lentivirus) require cell division to integrate their DNA into the host genome to remain stably transduced ; therefore, the limited proliferative nature of primary human macrophages does not favor the use of this viral vector.
Lentiviruses like HIV have the capacity to infect non-dividing and dividing cells and to integrate into the host cell genome [16–20]. Due to these characteristics, HIV-based lentiviral vectors have been proposed as good delivery system candidates for gene therapy, but the attempt to use them in clinical trials has raised concerns about their safety including the risk of genetic recombination leading to the generation of replication-competent retrovirus in humans. Further modifications in the packaging and genetic components of viral genes have been carried out to develop safer HIV-based lentiviral vector systems [21–24]. Due to our interest in gene manipulation of human M-CSF differentiated monocyte-derived macrophages, the objective of this study was to determine transduction efficiency of primary human blood M-CSF differentiated monocyte-derived macrophages transduced with two VSV-G pseudotyped HIV-1 based lentiviral delivery systems.
Determination of optimal time to transduce
The results showed that the highest transduction efficiency was reached when monocytes were transduced 2 hours after plating. On the other hand, the amount of fluorescence intensity per cell did not correlate (r = 0.46, p = 0.54) with time of transduction (Figure 1B). Considering these findings, in order to achieve the highest transduction efficiency, all following experiments were performed 2 hours after monocyte plating.
Determination of optimal multiplicity of infection
On day 7, all VRX494-transduced cultures showed EGFP-positive cells (Figure 2). On day 8, % EGFP-positive cells and fluorescence intensity were quantified using flow cytometry. In all transduced cultures a peak shift corresponding to the presence of EGFP-positive cells was found (Figure 3). Transduction efficiency ranged between 8 and 58%, and a positive correlation (r = 0.99, p = 0.007) between MOI and % EGFP-positive cells was found. However, the fluorescence intensity per cell showed a trend toward lower values with higher MOIs used for transduction (Figure 4A).
Photomicrographs of cultures transduced with VRX1090 showed EGFP-positive cells in all conditions (Figure 2). However, at an MOI of 25 and 50 a decrease in cell density compared to non-transduced control was observed by phase microscopy. On day 8, flow cytometry analysis was performed. Since the cell density of the culture transduced with an MOI of 50 was very low, there were insufficient cells for flow cytometry analysis. In all conditions, flow cytometry analysis histograms showed a peak shift for transduced cells when compared with non-transduced cells (Figure 3). All transductions were highly efficient with a range between 56 and 80% EGFP-positive cells. However, % EGFP and mean fluorescence intensity per cell showed no correlation with the MOIs used for transduction (Figures 3 and 4A).
Transduction efficiency of human blood monocyte-derived macrophages using different MOIs
% EGFP-positive cells
G-tag copies per cell
Primary cells are usually more difficult to transfect or transduce than their similar immortalized cell lines , and macrophages are one of the most resistant cell types to gene transfer . Therefore, obtaining efficient gene transfer in primary human blood monocyte-derived macrophages could be challenging.
In this report, we found that the best time to transduce human blood monocytes was 2 hours after cell plating. There were progressively fewer EGFP-positive cells when macrophage cultures were transduced at later times following plating of the cells. The differences between transduction time and time of flow cytometry quantification probably do not explain the negative correlation found between time of transduction and % EGFP positive cells. EGFP is a stable protein with a turnover of approximately 10% in 3 hours, whose expression can be detected 24-48 hours after its cDNA has been transferred into various mammalian cell types . Since all transductions in our cell cultures were performed between 72 hours and 192 hours before quantification, it is reasonable to conclude that by the time of flow cytometry quantification, all transduced cultures should have already reached their plateau of EGFP concentration. Thus, the difference observed between each group was likely due to differences in transduction efficiency rather than due to the differences in time of flow cytometry quantification. These findings suggest that monocyte-derived macrophages during the early phases of differentiation are highly transducible with VRX1090, but later they become less susceptible to transduction; the less differentiated the higher the transduction efficiency. However, we cannot exclude the possibility that more differentiated macrophages transduced for longer times would produce higher transduction efficiencies. In any case, transduction at later times after cell plating was associated with lower macrophage cell density, another factor favoring transduction at 2 hours after plating as the optimal time for transduction.
The possibility that macrophages phagocytosed EGFP derived from lentiviral solution contaminated with EGFP expressed during generation of the lentivirus from infected producer cells (i.e., pseudotransduction) cannot explain these findings. In such a case, the results would have been the opposite. In pseudotransduction, cells initially take up EGFP but then metabolize it without producing new EGFP. Thus, in pseudotransduction the cultures that were transduced later should have shown a higher proportion of EGFP-positive cells. Since this is the opposite of the pattern observed in this experiment, pseudotransduction was probably minimal.
Cultures transduced 24, 48 and 120 hour after plating showed a decrease in cell density when compared with the non-transduced control cultures transduced at 2-hours after plating. Since all cultures transduced 24 hours after plating were in the process of macrophage differentiation , it is possible that lentivirus addition in these cultures decreased cell proliferation or affected the differentiation of monocytes into macrophages to some degree thereby indirectly decreasing macrophage survival. The possibility of direct lentivirus-induced cell toxicity is remote, because it is well established that cell-induced toxicity correlates with exposure time. In our experiments, the culture with the longest exposure time to the lentivirus was the culture transduced 2 hours after plating. This culture showed the highest cell density compared with the other transduced cultures, so direct lentivirus-induced cell toxicity cannot explain the decrease in cell density. Mean fluorescence intensity per cell did not correlate with transduction time, suggesting that the amount of EGFP expressed per transduced cells is independent of transduction and macrophage differentiation time.
Our findings show that both lentiviruses at any of the various concentrations used were able to transduce monocyte-derived macrophages and produce EGFP in amounts sufficient for detection. Results of transducing monocyte-derived macrophages with VRX494 were similar to those observed in previous reports using viral transducing systems, higher MOIs resulted in higher frequency of cells that were transduced [20, 28, 29]. Transductions performed with VRX1090 showed a higher frequency of transduced cells than VRX494, but cells transduced with VRX494 showed higher fluorescence intensity per cell. These differences could be explained mostly by macrophage response during transduction (e.g., activation, promoter expression). Since each lentiviral vector used in this study requires a different promoter for protein expression, it is possible that differences in promoter and cell activity could have been responsible of the differences in the levels of EGFP expression. There is less possibility that intrinsic differences between the 2 lentiviruses (e.g., particle size, stability) could explain the differences found between both vectors since the same system was used to generate both lentiviruses.
Transduction efficiency* of human blood monocyte-derived macrophages using different viral systems
Haddada H, et al. 
Huang S, et al. 
Schneider SD, et al. 
De S, et al. 
Foxwell B, et al. 
Beta-gal activity flow cytometry
Heider H, et al. 
GFP fluorescence microscopy
White S, et al. 
HIV/SIV based lentivirus
GFP fluorescence microscopy
Schroers R, et al. 
HIV based lentivirus
YFP flow cytometry
Neil S, et al. 
HIV based lentivirus
GFP flow cytometry
Ravot E, et al. 
HIV based lentivirus
GFP flow cytometry
Lu Y, et al. 
HIV based lentivirus
GFP fluorescence microscopy
Jarrosson-Wuilleme L, et al. 
HIV based lentivirus
GFP flow cytometry
Zeng L, et al. 
HIV based lentivirus
GFP fluorescence microscopy
HIV based lentivirus
EGFP flow cytometry
Our finding that the optimal time to transduce M-CSF differentiated macrophages was better when these macrophages were less differentiated contrasts with the previous findings reported by Zeng et al.  in which less differentiated macrophages were more resistant to transduction. However, Zeng et al. reported transducing macrophages following differentiation with human serum, which produces the GM-CSF macrophage phenotype in contrast to the M-CSF macrophage phenotype we have studied here. Zeng et al. also transduced the macrophages in the presence of polybrene. We did not use polybrene in our experiments because we observed that polybrene was toxic to human M-CSF differentiated monocyte-derived macrophages (unpublished observation).
If higher MOIs are excluded, where donor-dependent a cell density decrease was usually observed, our study shows that transducing M-CSF differentiated monocyte-derived macrophages with VRX1090 lentivirus using an MOI of 10 consistently gives 80-90% transduction efficiency with no observed decrease in cell density. Thus, we show for first time that HIV-based lentiviruses can efficiently transduce M-CSF differentiated human blood monocyte-derived macrophages early during differentiation using a low MOI that will not interfere with the cell differentiation process or induce a decrease in cell density.
Human blood monocytes were collected from three healthy blood donors (donor 1, 2 and 3) and purified with counterflow centrifugal elutriation of mononuclear cells . Human blood cell collections were done by the Department of Transfusion Medicine, Clinical Center, National Institutes of Health, under a human subjects research protocol approved by a National Institutes of Health institutional review board and in agreement with the Helsinki Declaration. Cells were plated at 2 × 105 cells per cm2 in 6-well CellBIND plates (Corning, Corning, NY), and cultured in RPMI 1640 medium (Mediatech, Herndon, VA) with 10% FBS (Invitrogen, Carlsbad, CA). After 2-hours in a cell culture incubator with 5% CO2/95% air at 37ºC, cells were rinsed 3 times with RPMI 1640 medium and then cultured in 3 ml RPMI 1640 medium with 10% FBS, 50 ng/ml M-CSF, and 25 ng/ml IL-10, both of the latter obtained from PeproTech (Rocky Hill, NJ). IL-10 was used to induce differentiation of monocytes into macrophages, since IL-10 used together with M-CSF increases M-CSF receptor expression which enhances the macrophage differentiation process . Cell cultures were fed with fresh medium after five days.
Two vesicular stomatitis virus G protein (VSV-G) pseudotyped HIV-1 based lentiviral vectors encoding the enhanced green fluorescent protein (EGFP) driven by either the native HIV LTR promoter (VRX494, derived from NL4-3, Clade B) or the constitutive EF1α promoter in a SIN configuration (VRX1090), both produced by VIRxSYS Corporation (Gaithersburg, MD) were used for these studies. Vectors were produced as previously described [40, 41]. In brief, HEK293 cells were transfected using calcium phosphate with the VIRPAC packaging construct, a single packaging plasmid that co-expresses Gag-Pol, Tat, Rev, and VSV-G. Supernatant containing lentiviral particles were collected every 12 h from 24 to 48 h after transfection, concentrated by high-speed centrifugation at 10,000 g for 12 h, and titered by Q-PCR (determination of number of transducing or infectious units per ml) on HeLa-tat cells. Titers for VRX494 and VRX1090 were 3 × 109 TU/ml (p24 = 47 ug/ml) and 3.9 × 109 TU/ml (p24 = 92 ug/ml) respectively.
Transduction of macrophages
Cultured monocyte-derived macrophages were transduced separately with lentiviral vectors VRX494 and VRX1090. Lentiviral vectors were added directly into each well containing 3 ml of culture medium at different Hela-tat based multiplicities of infection (MOI-defined as the number of lentiviral particles able to transduce used per Hela-tat cell). Macrophage transduction efficiency, defined as percentage of transduced cells expressing EGFP and mean fluorescence intensity, was assessed qualitatively using an Olympus IX81 fluorescence microscope (Center Valley, PA) equipped with an FITC filter, and quantitatively using a FACSCalibur flow cytometer (Becton Dickinson Biosciences, San Jose, CA). Because a cell suspension was required for flow cytometry analysis, cells were scraped from each well after a 5-minute incubation with Cellstripper solution (Mediatech), a non-enzymatic cell dissociation mixture of chelators. Non-transduced cells serving as controls also were analyzed with the cytometer. Gating was set on light scatter to include cells while excluding debris. EGFP fluorescence was measured using the 525 nm bandpass channel. EGFP positive cells were defined as those cells having fluorescence intensity greater than the non-transduced control cells. The mean geometric fluorescence intensity per EGFP-positive cell was determined. Data were analyzed using FCS Express version 3 (De Novo Software, Los Angeles, CA).
Determination of vector copy number per cell
Transduced monocyte-derived macrophages were scraped from each well after a 5-minute incubation with Cellstripper solution (Mediatech). Total genomic DNA was extracted and purified using a QIAamp DNA Micro Kit from Qiagen (Valencia, CA). Vector-specific real-time PCR analysis using primers and probes specific for GFP cDNA (G-tag) were carried out to determine the number of integrated viral genomes. Cell numbers were estimated by measuring the number of β-globin DNA copies per sample by real-time PCR as previously described .
Data was analyzed using Pearson’s correlation coefficient. Statistical analyses were performed using Prism 4 for Windows version 4.00 (GraphPad Software, Inc., La Jolla, CA). Alpha error was set at p < 0.05.
The authors thank VIRxSYS Corporation for providing the HIV-based lentiviral vectors VRX494 and VRX1090 and determining vector copy numbers; Madaiah Puttaraju, Nikolay Korokhov, and Laurent M. Humeau from VIRxSYS for helpful suggestions about this work and manuscript; Peg Koelble from the NHLBI Office of Technology Transfer and Development; and Rex Robinson from the NIH library for the review of the manuscript. This research was supported in part by the NHLBI intramural research program.
- Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B: Deaths: Final Data for 2006. National Vital Statistics Report. Edited by: CDC. 2009, Hyattsville, 57: 1-80.Google Scholar
- Kruth HS: Lipoprotein cholesterol and atherosclerosis. Curr Mol Med. 2001, 1 (6): 633-653. 10.2174/1566524013363212.View ArticleGoogle Scholar
- Libby P: Inflammation in atherosclerosis. Nature. 2002, 420 (6917): 868-874. 10.1038/nature01323.View ArticleGoogle Scholar
- Kruth HS: Macrophage foam cells and atherosclerosis. Front Biosci. 2001, 6: D429-455. 10.2741/Kruth.View ArticleGoogle Scholar
- Burke B, Sumner S, Maitland N, Lewis CE: Macrophages in gene therapy: cellular delivery vehicles and in vivo targets. J Leukoc Biol. 2002, 72 (3): 417-428.Google Scholar
- Kruth HS, Jones NL, Huang W, Zhao B, Ishii I, Chang J, Combs CA, Malide D, Zhang WY: Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density lipoprotein. J Biol Chem. 2005, 280 (3): 2352-2360. 10.1074/jbc.M407167200.View ArticleGoogle Scholar
- Waldo SW, Li Y, Buono C, Zhao B, Billings EM, Chang J, Kruth HS: Heterogeneity of human macrophages in culture and in atherosclerotic plaques. Am J Pathol. 2008, 172 (4): 1112-1126. 10.2353/ajpath.2008.070513.View ArticleGoogle Scholar
- Zhao B, Li Y, Buono C, Waldo SW, Jones NL, Mori M, Kruth HS: Constitutive receptor-independent low density lipoprotein uptake and cholesterol accumulation by macrophages differentiated from human monocytes with macrophage-colony-stimulating factor (M-CSF). J Biol Chem. 2006, 281 (23): 15757-15762. 10.1074/jbc.M510714200.View ArticleGoogle Scholar
- Anzinger JJ, Chang J, Xu Q, Buono C, Li Y, Leyva FJ, Park BC, Greene LE, Kruth HS: Native low-density lipoprotein uptake by macrophage colony-stimulating factor-differentiated human macrophages is mediated by macropinocytosis and micropinocytosis. Arterioscler Thromb Vasc Biol. 2010, 30 (10): 2022-2031. 10.1161/ATVBAHA.110.210849.View ArticleGoogle Scholar
- Burke B: Macrophages as novel cellular vehicles for gene therapy. Expert Opin Biol Ther. 2003, 3 (6): 919-924. 10.1517/147125220.127.116.119.View ArticleGoogle Scholar
- Diao J, Smythe JA, Smyth C, Rowe PB, Alexander IE: Human PBMC-derived dendritic cells transduced with an adenovirus vectorinduce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro. Gene Ther. 1999, 6 (5): 845-853. 10.1038/sj.gt.3300899.View ArticleGoogle Scholar
- Foxwell B, Browne K, Bondeson J, Clarke C, de Martin R, Brennan F, Feldmann M: Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent. Proc Natl Acad Sci USA. 1998, 95 (14): 8211-8215. 10.1073/pnas.95.14.8211.View ArticleGoogle Scholar
- Haddada H, Lopez M, Martinache C, Ragot T, Abina MA, Perricaudet M: Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages. Biochem Biophys Res Commun. 1993, 195 (3): 1174-1183. 10.1006/bbrc.1993.2168.View ArticleGoogle Scholar
- Heider H, Verca SB, Rusconi S, Asmis R: Comparison of lipid-mediated and adenoviral gene transfer in human monocyte-derived macrophages and COS-7 cells. Biotechniques. 2000, 28 (2): 260-265. 268-270Google Scholar
- Miller DG, Adam MA, Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol. 1990, 10 (8): 4239-4242.View ArticleGoogle Scholar
- Corbeau P, Kraus G, Wong-Staal F: Transduction of human macrophages using a stable HIV-1/HIV-2-derived gene delivery system. Gene Ther. 1998, 5 (1): 99-104. 10.1038/sj.gt.3300563.View ArticleGoogle Scholar
- Miyake K, Suzuki N, Matsuoka H, Tohyama T, Shimada T: Stable integration of human immunodeficiency virus-based retroviral vectors into the chromosomes of nondividing cells. Hum Gene Ther. 1998, 9 (4): 467-475. 10.1089/hum.1998.9.4-467.View ArticleGoogle Scholar
- Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996, 272 (5259): 263-267. 10.1126/science.272.5259.263.View ArticleGoogle Scholar
- Neil S, Martin F, Ikeda Y, Collins M: Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes. J Virol. 2001, 75 (12): 5448-5456. 10.1128/JVI.75.12.5448-5456.2001.View ArticleGoogle Scholar
- Schroers R, Sinha I, Segall H, Schmidt-Wolf IG, Rooney CM, Brenner MK, Sutton RE, Chen SY: Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system. Mol Ther. 2000, 1 (2): 171-179. 10.1006/mthe.2000.0027.View ArticleGoogle Scholar
- Lu Y, Liu C, Zeng L, Lin Z, Dewhurst S, Gartner S, Planelles V: Efficient gene transfer into human monocyte-derived macrophages using defective lentiviral vectors. Cell Mol Biol (Noisy-le-grand). 2003, 49 (7): 1151-1156.Google Scholar
- Wu X, Wakefield JK, Liu H, Xiao H, Kralovics R, Prchal JT, Kappes JC: Development of a novel trans-lentiviral vector that affords predictable safety. Mol Ther. 2000, 2 (1): 47-55. 10.1006/mthe.2000.0095.View ArticleGoogle Scholar
- Levine BL, Humeau LM, Boyer J, MacGregor RR, Rebello T, Lu X, Binder GK, Slepushkin V, Lemiale F, Mascola JR, Bushman FD, Dropulic B, June CH: Gene transfer in humans using a conditionally replicating lentiviral vector. Proc Natl Acad Sci USA. 2006, 103 (46): 17372-17377. 10.1073/pnas.0608138103.View ArticleGoogle Scholar
- Wang GP, Levine BL, Binder GK, Berry CC, Malani N, McGarrity G, Tebas P, June CH, Bushman FD: Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cells. Mol Ther. 2009, 17 (5): 844-850. 10.1038/mt.2009.16.View ArticleGoogle Scholar
- Hamm A, Krott N, Breibach I, Blindt R, Bosserhoff AK: Efficient transfection method for primary cells. Tissue Eng. 2002, 8 (2): 235-245. 10.1089/107632702753725003.View ArticleGoogle Scholar
- Li X, Zhao X, Fang Y, Jiang X, Duong T, Fan C, Huang CC, Kain SR: Generation of destabilized green fluorescent protein as a transcription reporter. J Biol Chem. 1998, 273 (52): 34970-34975. 10.1074/jbc.273.52.34970.View ArticleGoogle Scholar
- Hashimoto S, Yamada M, Motoyoshi K, Akagawa KS: Enhancement of macrophage colony-stimulating factor-induced growth and differentiation of human monocytes by interleukin-10. Blood. 1997, 89 (1): 315-321.Google Scholar
- Jarrosson-Wuilleme L, Goujon C, Bernaud J, Rigal D, Darlix JL, Cimarelli A: Transduction of nondividing human macrophages with gammaretrovirus-derived vectors. J Virol. 2006, 80 (3): 1152-1159. 10.1128/JVI.80.3.1152-1159.2006.View ArticleGoogle Scholar
- Zeng L, Planelles V, Sui Z, Gartner S, Maggirwar SB, Dewhurst S, Ye L, Nerurkar VR, Yanagihara R, Lu Y: HIV-1-based defective lentiviral vectors efficiently transduce human monocytes-derived macrophages and suppress replication of wild-type HIV-1. J Gene Med. 2006, 8 (1): 18-28. 10.1002/jgm.825.View ArticleGoogle Scholar
- Huang S, Endo RI, Nemerow GR: Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J Virol. 1995, 69 (4): 2257-2263.Google Scholar
- De SK, Venkateshan CN, Seth P, Gajdusek DC, Gibbs CJ: Adenovirus-mediated human immunodeficiency virus-1 Nef expression in human monocytes/macrophages and effect of Nef on downmodulation of Fcgamma receptors and expression of monokines. Blood. 1998, 91 (6): 2108-2117.Google Scholar
- Ravot E, Comolli G, Lori F, Lisziewicz J: High efficiency lentiviral gene delivery in non-dividing cells by deoxynucleoside treatment. J Gene Med. 2002, 4 (2): 161-169. 10.1002/jgm.256.View ArticleGoogle Scholar
- Schneider SD, Rusconi S, Seger RA, Hossle JP: Adenovirus-mediated gene transfer into monocyte-derived macrophages of patients with X-linked chronic granulomatous disease: ex vivo correction of deficient respiratory burst. Gene Ther. 1997, 4 (6): 524-532. 10.1038/sj.gt.3300432.View ArticleGoogle Scholar
- White SM, Renda M, Nam NY, Klimatcheva E, Zhu Y, Fisk J, Halterman M, Rimel BJ, Federoff H, Pandya S, Rosenblatt JD, Planelles V: Lentivirus vectors using human and simian immunodeficiency virus elements. J Virol. 1999, 73 (4): 2832-2840.Google Scholar
- Wickham TJ, Mathias P, Cheresh DA, Nemerow GR: Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell. 1993, 73 (2): 309-319. 10.1016/0092-8674(93)90231-E.View ArticleGoogle Scholar
- Yee JK, Friedmann T, Burns JC: Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol. 1994, 43 (Pt A): 99-112. full_text.View ArticleGoogle Scholar
- Carter GC, Bernstone L, Baskaran D, James W: HIV-1 infects macrophages by exploiting an endocytic route dependent on dynamin, Rac1 and Pak1. Virology. 2011, 409 (2): 234-250. 10.1016/j.virol.2010.10.018.View ArticleGoogle Scholar
- Quinn K, Brindley MA, Weller ML, Kaludov N, Kondratowicz A, Hunt CL, Sinn PL, McCray PB, Stein CS, Davidson BL, Flick R, Mandell R, Staplin W, Maury W, Chiorini JA: Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors. J Virol. 2009, 83 (19): 10176-10186. 10.1128/JVI.00422-09.View ArticleGoogle Scholar
- Kruth HS, Skarlatos SI, Lilly K, Chang J, Ifrim I: Sequestration of acetylated LDL and cholesterol crystals by human monocyte-derived macrophages. J Cell Biol. 1995, 129 (1): 133-145. 10.1083/jcb.129.1.133.View ArticleGoogle Scholar
- Humeau LM, Binder GK, Lu X, Slepushkin V, Merling R, Echeagaray P, Pereira M, Slepushkina T, Barnett S, Dropulic LK, Carroll R, Levine BL, June CH, Dropulic B: Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load. Mol Ther. 2004, 9 (6): 902-913. 10.1016/j.ymthe.2004.03.005.View ArticleGoogle Scholar
- Lu X, Humeau L, Slepushkin V, Binder G, Yu Q, Slepushkina T, Chen Z, Merling R, Davis B, Chang YN, Dropulic B: Safe two-plasmid production for the first clinical lentivirus vector that achieves > 99% transduction in primary cells using a one-step protocol. J Gene Med. 2004, 6 (9): 963-973. 10.1002/jgm.593.View ArticleGoogle Scholar
- O'Doherty U, Swiggard WJ, Malim MH: Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol. 2000, 74 (21): 10074-10080.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.